Procyon Corporation (PCYN)

Market Cap	1.55M
Revenue (ttm)	4.98M
Net Income (ttm)	-312.96K
Shares Out	8.14M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	350
Average Volume	13,700
Open	0.1900
Previous Close	0.0013
Day's Range	0.1900 - 0.1900
52-Week Range	0.0000 - 0.3380
Beta	53,899.96
RSI	50.58
Earnings Date	Sep 26, 2025

About Procyon

Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: PCYN

Financial Performance

In 2024, Procyon's revenue was $4.98 million, an increase of 6.35% compared to the previous year's $4.69 million. Losses were -$312,962, 367.4% more than in 2023.